HSI Newsletter
In this issue, we announce registration for several HSI lunchtime seminars in April.
In this issue, we announce registration for several HSI lunchtime seminars in April.
By
Climate tech company BlocPower specializes in residential building electrification, which improves human health and reduces healthcare costs. But no funding exists to link electrification to preventative healthcare efforts. A team of S-Lab students stepped in to help BlocPower make the link.
Researchers from MIT Sloan both clarify and analyze historical impacts of news headlines on biotechnology and pharmaceutical companies.
Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
By
Rajiv Shah, president of The Rockefeller Foundation and former administrator of USAID, believes in leveraging the passion of individuals to affect large-scale change in society.
By
Takeda is a global biopharmaceutical corporation with an ambitious zero-waste-to-landfill goal. BioLife, a subsidiary of Takeda, sought to develop prioritized recycling strategies in support of Takeda’s sustainability pledge and goals. A team of three Sustainable Business Lab (S-Lab) students tackle...
By
Steve Rusckowski, SM ’84, former chairperson, CEO, and president of Quest Diagnostics, believes small changes can have a major impact on company culture.
An intensive food-as-medicine program showed no improvement in glycemic control in patients with type 2 diabetes and food insecurity: MIT Sloan.
"Randomized clinical trials are key tools for discerning what works best, for whom and why, information that we should all be hungry for."
Study of rigorous trial, co-authored by Erwin H. Schell Professor Joseph Doyle, shows mixed results and suggests need to keep examining how nutrition can combat a pervasive disease.